Steriscience Specialties Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Steriscience Specialties Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $23.8M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Steriscience Specialties Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $23.8M Trade | TransData Nexus

Steriscience Specialties Private Limited

Indian Pharmaceutical Exporter · Antibiotics Specialist · $23.8M Total Trade · DGFT Verified

Steriscience Specialties Private Limited is an Indian pharmaceutical exporter with a total trade value of $23.8M across 4 products in 4 therapeutic categories. Based on 486 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ampicillin ($12.9M), Piperacillin ($9.8M), Methylprednisolone ($700.0K).

Steriscience Specialties Private Limited — Export Portfolio & Destination Treemap

Steriscience Specialties Private Limited pharmaceutical export portfolio — 4 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Steriscience Specialties Private Limited? — Company Overview & Market Position

Steriscience Specialties Private Limited is a privately held pharmaceutical company based in Thane, Maharashtra, India. Established on August 29, 2020, the company specializes in the formulation and development of finished pharmaceutical products, including tablets, capsules, syrups, and injections. The Corporate Identification Number (CIN) assigned to the company is U24304MH2020PTC424881.

As of March 31, 2024, Steriscience reported an authorized capital of ₹5.5 million and a paid-up capital of ₹0.21 million. The company employs approximately 770 professionals, reflecting its commitment to growth and operational excellence. The registered office is located at 201, Devavrata, Sector 17, Vashi, Navi Mumbai, Thane, Maharashtra, 400703.

What Does Steriscience Specialties Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ampicillin$12.9M 2Piperacillin

Product Portfolio — Top 4 by Export Value

Steriscience Specialties Private Limited exports 4 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ampicillin	Antibiotics	$12.9M	259	9.1%	2
2	Piperacillin	Advanced Antibiotics	$9.8M	195	11.1%	2
3	Methylprednisolone	Corticosteroids	$700.0K	14	2.4%	7
4	Vati	Ayurvedic & Herbal Products	$369.7K	18	1.4%	12

Steriscience Specialties Private Limited exports 4 pharmaceutical products across 4 therapeutic categories with a total export value of $23.8M. The top category is Antibiotics (54.5% of portfolio), followed by Advanced Antibiotics (41.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Steriscience Specialties Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Steriscience operates two state-of-the-art manufacturing facilities:

1. Poland Facility: Acquired in 2020, this facility holds European Union Good Manufacturing Practice (EU GMP) approval, enabling the company to produce high-quality pharmaceutical products for the European market.

2. Brooks' Carbapenems Facility, India: In 2021, Steriscience acquired a majority stake in this facility, enhancing its capacity to produce specialized injectable antibiotics.

3Key Leadership

The leadership team at Steriscience includes:

Chandrappa Seetharamaiah: Director since June 2, 2021.

Chhitiz Saraogi: Director since May 17, 2024.

These leaders bring extensive experience in the pharmaceutical industry, guiding the company's strategic direction and operational growth.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Steriscience Specialties Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Steriscience has made significant strides in obtaining regulatory approvals for its products:

United States: The company received its first Abbreviated New Drug Application (ANDA) approval in 2022, marking its entry into the U.S. market.

European Union: In 2022, Steriscience secured its first product approval in the EU, facilitated by its Poland facility's EU GMP certification.

United Kingdom: While specific approvals are not detailed, the EU GMP certification of the Poland facility suggests potential market access in the UK.

Australia: No specific regulatory filings or approvals are reported.

Japan: No specific regulatory filings or approvals are reported.

2Emerging Markets

Steriscience Specialties Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Steriscience's engagement with the U.S. Food and Drug Administration (FDA) includes:

FDA Facility Registrations: The company has registered its manufacturing facilities with the FDA, ensuring compliance with U.S. regulations.

Approved ANDAs: Steriscience received its first ANDA approval in 2022, allowing it to market generic drugs in the U.S.

DMF Filings: Specific details regarding Drug Master File (DMF) filings are not publicly disclosed.

Inspection History: No adverse inspection outcomes, such as Form 483 observations or warning letters, have been reported.

2WHO & EU GMP

Steriscience Specialties Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Steriscience operates in a competitive pharmaceutical industry, facing competition from both established and emerging companies. Its focus on sterile injectables and specialized formulations positions it uniquely in the market. While specific market share data is not publicly disclosed, the company's strategic acquisitions and regulatory approvals indicate a strong competitive stance.

2Key Differentiators

Steriscience's unique strengths include:

Specialized Product Portfolio: The company focuses on value-added sterile injectables, addressing specific needs in hospital settings.

Regulatory Compliance: Steriscience's adherence to international standards, including WHO prequalification and EU GMP certification, underscores its commitment to quality.

Strategic Acquisitions: The acquisition of facilities in Poland and India enhances the company's manufacturing capabilities and market reach.

Buyer Due Diligence Brief — Evaluating Steriscience Specialties Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Steriscience's track record as a supplier is characterized by:

Export Volume and Consistency: The company has demonstrated consistent export activity, with a total export value of $23.8 million USD across 486 shipments from 2022 to 2026.

Reliability Indicators: The absence of adverse regulatory actions and the company's adherence to international standards suggest a reliable supply chain.

2Certifications to Verify

Importers should verify the following certifications when considering Steriscience as a supplier:

FDA Registration: Confirm the company's FDA facility registrations to ensure compliance with U.S. regulations.

WHO-GMP Certification: Verify the company's WHO prequalification status to ensure product quality.

Frequently Asked Questions — Steriscience Specialties Private Limited

How many pharmaceutical products does Steriscience Specialties Private Limited export from India?

Steriscience Specialties Private Limited exports 4 pharmaceutical products across 4 therapeutic categories. The top exports are Ampicillin ($12.9M), Piperacillin ($9.8M), Methylprednisolone ($700.0K), Vati ($369.7K). Total export value is $23.8M.

What is Steriscience Specialties Private Limited's total pharmaceutical export value?

Steriscience Specialties Private Limited's total pharmaceutical export value is $23.8M, based on 486 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Steriscience Specialties Private Limited cover?

Steriscience Specialties Private Limited exports across 4 therapeutic categories. The largest are Antibiotics (54.5%, 1 products), Advanced Antibiotics (41.0%, 1 products), Corticosteroids (2.9%, 1 products).

Get Full Steriscience Specialties Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.